Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men

O Dotsenko1, N Chaturvedi, S A McG Thom

  • 1International Centre for Circulatory Health, NHLI Division, Faculty of Medicine, St Mary's Hospital and Imperial College London, London, UK.

Insights

Platelet activation, indicated by platelet-monocyte complexes (PMC), is linked to aortic and femoral atherosclerosis, not coronary or carotid disease. Inflammation may drive this platelet activation in generalized atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Inflammation and Immunology

Background:

  • Platelet activation is observed in ischemic heart disease (IHD) and other atherosclerotic conditions.
  • The role of platelet activation as a marker for IHD versus generalized atherosclerosis and inflammation is unclear.
  • Ethnic differences in platelet and leukocyte function between European and South Asian subjects at high risk for IHD are not well understood.

Purpose of the Study:

  • To investigate the relationship between platelet and leukocyte activation markers and the extent of atherosclerosis in different vascular beds.
  • To determine if platelet activation is associated with generalized atherosclerosis, inflammation, or specific vascular diseases.
  • To explore potential ethnic differences in platelet and leukocyte function.

Main Methods:

  • Fifty-four male subjects (age 49-79) underwent assessments for coronary artery calcification (CT), aortic atherosclerosis (aortic pulse wave velocity), and femoral/carotid atherosclerosis (ultrasound).
  • Platelet and leukocyte activation were measured using flow cytometry, assessing platelet-monocyte complexes (PMC), platelet PAC-1 binding, CD62P expression, and leukocyte L-selectin expression.
  • Multivariate analysis was used to identify independent predictors of PMC levels.

Main Results:

  • Elevated circulating PMC significantly correlated with increased aortic pulse wave velocity and higher prevalence of femoral plaques.
  • PMC levels did not differ based on coronary artery calcification severity or the presence of carotid plaques.
  • Higher PMC counts were independently associated with elevated C-reactive protein (CRP), higher aortic pulse wave velocity, hypertension, and smoking.
  • No significant ethnic differences were found in markers of platelet and leukocyte activation.

Conclusions:

  • Increased platelet-monocyte complexes are associated with the extent of aortic and femoral atherosclerosis, but not coronary or carotid atherosclerosis.
  • The strong association between elevated CRP and increased PMC suggests a significant role for inflammation in generalized atherosclerosis-related platelet activation.
  • Platelet and leukocyte activation markers do not appear to differ significantly between European and South Asian subjects in this cohort.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...